SPY415.87+4.42 1.07%
DIA340.44+2.91 0.86%
IXIC14,038.76+180.92 1.31%

Codiak BioSciences Q4 EPS $(1.14) Beats $(1.54) Estimate, Sales $1.64M Up From $150.00K YoY

Codiak BioSciences (NASDAQ:CDAK) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.54) by 25.97 percent. The company reported $1.64 million in sales this quarter. This is a

· 03/17/2021 07:32
Codiak BioSciences (NASDAQ:CDAK) reported quarterly losses of $(1.14) per share which beat the analyst consensus estimate of $(1.54) by 25.97 percent. The company reported $1.64 million in sales this quarter. This is a 992.67 percent increase over sales of $150.00 thousand the same period last year.